Iluvien Registry Safety Study
NCT01998412 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 559
Last updated 2019-03-20
Summary
The study will include any patient treated with Iluvien at designated sites in European countries where marketing authorization has been granted in order to obtain broader safety and usage information.
Conditions
- Chronic Diabetic Macular Oedema Considered Insufficiently Responsive to Available Therapies
Sponsors & Collaborators
-
Alimera Sciences
lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-12-31
- Primary Completion
- 2020-01-31
- Completion
- 2020-01-31
Countries
- United States
Study Locations
More Related Trials
-
Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema
NCT00387582 ·Status: COMPLETED ·Phase: PHASE2
-
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
NCT01318941 ·Status: COMPLETED
-
A Research Study to Evaluate the Effects of Repeated Intravitreal Injections on Bacteria Around the Eye
NCT01531842 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occlusion
NCT01123564 ·Status: UNKNOWN ·Phase: PHASE2
-
Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Intravitreal Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients.
NCT01942213 ·Status: COMPLETED
-
Combined Ranibizumab and Iluvien for Diabetic Macular Oedema
NCT03784443 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
SD-OCT-guided Intravitreal Ranibizumab Treatment in Choroidal Neovascularization Due to Myopia
NCT03409250 ·Status: COMPLETED ·Phase: PHASE4
-
Safety Tolerability and Efficacy of Intravitreal LMG324 in the Treatment of Neovascular Age-Related Macular Degeneration
NCT02398500 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Intravitreal Ranibizumab Treatment of Central Retinal Vein Occlusion With Macular Edema
NCT00403039 ·Status: COMPLETED ·Phase: PHASE1
-
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
NCT01580020 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion
NCT01724554 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Effect of Intravitreal Ranibizumab on Visual Acuity and Hard Exudate Resolution in the Treatment of Diabetic Macular Edema With Center Involved Edema and Lipid Exudates
NCT02448446 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot Study
NCT00855608 ·Status: UNKNOWN ·Phase: PHASE1
-
Observation of Treatment Patterns With Lucentis in Approved Indications
NCT02194803 ·Status: COMPLETED
-
LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye
NCT03711929 ·Status: TERMINATED ·Phase: PHASE3
-
A Real-World Evidence Study for the Incidence of Retinal Vasculitis (RV) Among Adult Patients Receiving Aflibercept 2 mg in the United States (US)
NCT06769412 ·Status: COMPLETED
-
Safety and Efficacy of Ranibizumab for Diabetic Macular Edema
NCT01982435 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis
NCT00404742 ·Status: COMPLETED ·Phase: PHASE3
-
Intravitreal Celecoxib for Chronic Uveitis
NCT02131012 ·Status: TERMINATED ·Phase: PHASE1
-
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
NCT01135914 ·Status: COMPLETED ·Phase: PHASE3
-
Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion
NCT01710839 ·Status: COMPLETED ·Phase: PHASE4
-
Investigates Improvement in Vision Following Switching From Avastin and Macugen Over to Lucentis
NCT00804934 ·Status: COMPLETED
-
Observation of Treatment Patterns With Lucentis® in Real-life Conditions in All Approved Indications
NCT04847895 ·Status: COMPLETED
-
Incidence of Retinal Vasculitis Among Patients Receiving Aflibercept: A US Real-World Evidence Study
NCT07105228 ·Status: COMPLETED
-
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
NCT01396083 ·Status: COMPLETED ·Phase: PHASE3